Coagulopathy and hemostasis management in patients undergoing liver transplantation: Defining a dynamic spectrum across phases of care
暂无分享,去创建一个
D. Al-Adra | K. Farsad | T. Nydam | M. Kriss | A. Hess | Pratima Sharma | M. Nadim | M. Cushing | C. Karvellas | N. Intagliata | R. Chadha | A. Pillai | B. Fortune | R. Lewandowski | D. Al‐Adra
[1] G. Su,et al. AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis. , 2021, Gastroenterology.
[2] C. Fondevila,et al. Is antivitamin K reversal required in patients with cirrhosis undergoing liver transplantation? , 2021, Transfusion.
[3] C. Gillette,et al. Safety of direct oral anticoagulants in patients with mild to moderate cirrhosis: a systematic review and meta-analysis , 2021, Journal of Thrombosis and Thrombolysis.
[4] William M. Lee,et al. Coagulopathy, Bleeding Events, and Outcome According to Rotational Thromboelastometry in Patients With Acute Liver Injury/Failure , 2021, Hepatology.
[5] O. V. van Delden,et al. CIRSE Standards of Practice on Peri-operative Anticoagulation Management During Interventional Radiology Procedures , 2021, CardioVascular and Interventional Radiology.
[6] D. Al-Adra,et al. Defining postoperative transfusion thresholds in liver transplant recipients: A novel retrospective approach , 2020, Transfusion.
[7] D. Valla,et al. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases , 2020, Hepatology.
[8] A. Gottschalk,et al. Validation of predictive models identifying patients at risk for massive transfusion during liver transplantation and their potential impact on blood bank resource utilization , 2020, Transfusion.
[9] T. Lisman,et al. The Spectrum of Disease Severity in Cirrhosis and Its Implications for Hemostasis , 2020, Seminars in Thrombosis and Hemostasis.
[10] U. Merle,et al. Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and Non-ACLF patients , 2020, BMC Gastroenterology.
[11] William M. Lee,et al. VWF/ADAMTS13 Imbalance, But Not Global Coagulation or Fibrinolysis, Is Associated With Outcome and Bleeding in Acute Liver Failure , 2020, Hepatology.
[12] P. Northup,et al. Rates of Bleeding and Discontinuation of Direct Oral Anticoagulants in Patients with Decompensated Cirrhosis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[13] F. Wilson,et al. Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo‐coagulable and Hyper‐coagulable Features , 2020, Hepatology.
[14] David T. Huang,et al. Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary, and Renal Considerations , 2020, Critical care medicine.
[15] Motohiro Sekino,et al. Postoperative coagulation profiles of patients undergoing adult-to-adult living donor liver transplantation—A single-center experience , 2020 .
[16] M. Kumar,et al. Thromboelastography‐Guided Blood Component Use in Patients With Cirrhosis With Nonvariceal Bleeding: A Randomized Controlled Trial , 2020, Hepatology.
[17] F. Dentali,et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. , 2019, Blood advances.
[18] P. Pradat,et al. The use of a thromboelastometry-based algorithm reduces the need for blood product transfusion during orthotopic liver transplantation: A randomised controlled study. , 2019, European journal of anaesthesiology.
[19] V. Patel,et al. Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute‐on‐Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival , 2019, Hepatology.
[20] S. Caldwell,et al. Acute kidney injury is associated with low factor XIII in decompensated cirrhosis. , 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[21] S. Caldwell,et al. AGA Clinical Practice Update: Coagulation in Cirrhosis. , 2019, Gastroenterology.
[22] H. Eltzschig,et al. Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms , 2019, Liver international : official journal of the International Association for the Study of the Liver.
[23] S. Sarin,et al. Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute‐on‐chronic liver failure: An observational cohort study , 2019, Liver international : official journal of the International Association for the Study of the Liver.
[24] K. Simon,et al. Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L‐PLUS 2) , 2019, Hepatology.
[25] P. Kamath,et al. AGA Clinical Practice Update on Surgical Risk Assessment and Perioperative Management in Cirrhosis: Expert Review , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[26] Thomas G. Walker,et al. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions-Part II: Recommendations: Endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular , 2019, Journal of vascular and interventional radiology : JVIR.
[27] B. Kok,et al. Graft Dysfunction and Management in Liver Transplantation. , 2019, Critical care clinics.
[28] F. Aziz,et al. Coagulation Failure in Patients With Acute‐on‐Chronic Liver Failure and Decompensated Cirrhosis: Beyond the International Normalized Ratio , 2018, Hepatology.
[29] S. Kedia,et al. Thromboelastography Parameters in Patients with Acute on Chronic Liver Failure. , 2018, Annals of hepatology.
[30] T. Hassanein,et al. Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia. , 2018, Gastroenterology.
[31] G. Garcia‐Tsao,et al. Acute kidney injury, but not sepsis, is associated with higher procedure‐related bleeding in patients with decompensated cirrhosis , 2018, Liver international : official journal of the International Association for the Study of the Liver.
[32] A. Lebreton,et al. Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis , 2018, Journal of thrombosis and haemostasis : JTH.
[33] V. Patel,et al. In vitro efficacy of pro‐ and anticoagulant strategies in compensated and acutely ill patients with cirrhosis , 2018, Liver international : official journal of the International Association for the Study of the Liver.
[34] William M. Lee,et al. Bleeding complications in acute liver failure , 2018, Hepatology.
[35] J. Findlay,et al. Perioperative Coagulation Management in Liver Transplant Recipients , 2018, Transplantation.
[36] S. Caldwell,et al. Viscoelastic Testing in Liver Disease. , 2018, Annals of hepatology.
[37] V. Patel,et al. Balanced haemostasis with both hypo‐ and hyper‐coagulable features in critically ill patients with acute‐on‐chronic‐liver failure , 2018, Journal of critical care.
[38] D. Ganger,et al. Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort. , 2017, Journal of vascular and interventional radiology : JVIR.
[39] E. Moore,et al. Preoperative thrombelastography maximum amplitude predicts massive transfusion in liver transplantation. , 2017, The Journal of surgical research.
[40] E. Pomfret,et al. Liver transplant in patients with portal vein thrombosis: Medical and surgical requirements , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[41] A. Farcomeni,et al. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis. , 2017, Gastroenterology.
[42] M. Almegren. Reversal of direct oral anticoagulants , 2017, Vascular health and risk management.
[43] S. McCluskey,et al. The Effectiveness and Safety of Tranexamic Acid in Orthotopic Liver Transplantation Clinical Practice: A Propensity Score Matched Cohort Study , 2017, Transplantation.
[44] P. Wouters,et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. , 2017, European journal of anaesthesiology.
[45] S. Caldwell,et al. Reversal of direct oral anticoagulants for liver transplantation in cirrhosis: A step forward , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[46] A. Andriulli,et al. Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia. , 2017, European journal of internal medicine.
[47] Valerie Durkalski,et al. Development of a Model to Predict Transplant-free Survival of Patients With Acute Liver Failure. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[48] A. Sabaté,et al. Impact of Preemptive Fibrinogen Concentrate on Transfusion Requirements in Liver Transplantation: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[49] C. Zauner,et al. Coagulation parameters and major bleeding in critically ill patients with cirrhosis , 2016, Hepatology.
[50] M. Jiang,et al. Is Post-TIPS Anticoagulation Therapy Necessary in Patients with Cirrhosis and Portal Vein Thrombosis? A Randomized Controlled Trial. , 2016, Radiology.
[51] W. Nedel,et al. Thrombin activatable fibrinolysis inhibitor as a bleeding predictor in liver transplantation: a pilot observational study , 2016, Revista Brasileira de terapia intensiva.
[52] V. Agopian,et al. Incidence and risk factors for deep venous thrombosis and pulmonary embolus after liver transplantation. , 2016, American journal of surgery.
[53] William M. Lee,et al. Thrombocytopenia Is Associated With Multi-organ System Failure in Patients With Acute Liver Failure. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[54] M. Abouljoud,et al. Deep Vein Thrombosis and Pulmonary Embolism in Liver Transplant Patients: Risks and Prevention , 2016, Transplantation direct.
[55] R. Rahimi,et al. Transfusing common sense instead of blood products into coagulation testing in patients with cirrhosis: Overtreatment ≠ safety , 2016, Hepatology.
[56] R. Montalti,et al. Thrombelastography‐guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial , 2016, Hepatology.
[57] D. Sommacale,et al. Vascular complications following liver transplantation: A literature review of advances in 2015. , 2016, World journal of hepatology.
[58] M. Matsumoto,et al. Relevance of ADAMTS13 to liver transplantation and surgery. , 2015, World journal of hepatology.
[59] R. Stravitz,et al. Rebalanced Hemostasis in Patients with Acute Liver Failure , 2015, Seminars in Thrombosis & Hemostasis.
[60] F. Sztark,et al. Management of bleeding and transfusion during liver transplantation before and after the introduction of a rotational thromboelastometry–based algorithm , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[61] P. Hayes,et al. UK guidelines on the management of variceal haemorrhage in cirrhotic patients , 2000, Gut.
[62] R. de Franchis. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. , 2015, Journal of hepatology.
[63] P. Whiting,et al. Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. , 2015, Health technology assessment.
[64] V. Sundaram,et al. Incidence and risk factors of deep vein thrombosis after liver transplantation. , 2014, Transplantation proceedings.
[65] R. Porte,et al. Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation , 2014, F1000Research.
[66] G. Klintmalm,et al. The Role of Donor‐Specific HLA Alloantibodies in Liver Transplantation , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[67] Y. Maehara,et al. Management of thrombocytopenia due to liver cirrhosis: a review. , 2014, World journal of gastroenterology.
[68] S. Black,et al. Surgical and endovascular treatment of hepatic arterial complications following liver transplant , 2014, Clinical transplantation.
[69] P. Mannucci,et al. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis. , 2013, Journal of hepatology.
[70] M. Abouljoud,et al. Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review. , 2013, Transplantation proceedings.
[71] C. Bratton,et al. Early aspirin therapy may reduce hepatic artery thrombosis in liver transplantation. , 2013, Transplantation proceedings.
[72] D. Valla,et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. , 2012, Gastroenterology.
[73] D. Valla,et al. Portal vein thrombosis, cirrhosis, and liver transplantation. , 2012, Journal of hepatology.
[74] S. Hopewell,et al. Is fresh‐frozen plasma clinically effective? An update of a systematic review of randomized controlled trials (CME) , 2012, Transfusion.
[75] F. Nevens,et al. Risk factors for bleeding and clinical implications in patients undergoing liver transplantation. , 2012, Transplantation proceedings.
[76] P. Mannucci,et al. Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: considerations on the efficacy of treatment with fresh-frozen plasma , 2012, Internal and Emergency Medicine.
[77] P. Mannucci,et al. The coagulopathy of chronic liver disease. , 2011, The New England journal of medicine.
[78] E. Giannini,et al. Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[79] M. Tsou,et al. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. , 2010, Transplantation proceedings.
[80] A. Concejero,et al. Vascular Stents in the Management of Portal Venous Complications in Living Donor Liver Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[81] H. Khalaf. Vascular complications after deceased and living donor liver transplantation: a single-center experience. , 2010, Transplantation proceedings.
[82] R. Porte,et al. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. , 2010, Journal of hepatology.
[83] P. Mannucci,et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. , 2009, Gastroenterology.
[84] A. Andrei,et al. Designated liver transplant anesthesia team reduces blood transfusion, need for mechanical ventilation, and duration of intensive care , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[85] Johnny C. Hong,et al. Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. , 2009, Journal of the American College of Surgeons.
[86] K. D. de Jong,et al. Early Hepatic Artery Thrombosis after Liver Transplantation: A Systematic Review of the Incidence, Outcome and Risk Factors , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[87] B. Furie,et al. Mechanisms of thrombus formation. , 2008, The New England journal of medicine.
[88] A. Roy,et al. Coagulation Defects Do Not Predict Blood Product Requirements During Liver Transplantation , 2008, Transplantation.
[89] A. Khorana,et al. Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. , 2008, Thrombosis research.
[90] C. Clerici,et al. TAFI deficiency in liver cirrhosis: relation with plasma fibrinolysis and survival. , 2008, Thrombosis research.
[91] A. Sanyal,et al. Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis , 2007, The American Journal of Gastroenterology.
[92] H. Groen,et al. Efficacy and Safety of Antifibrinolytic Drugs in Liver Transplantation: A Systematic Review and Meta‐Analysis , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[93] A. Roy,et al. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[94] P. D. de Groot,et al. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity , 2006, Hepatology.
[95] A. Tripodi,et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests , 2005, Hepatology.
[96] V. Brancaccio,et al. Coagulation disorders in liver disease. , 2002, Seminars in liver disease.
[97] G. Klintmalm,et al. Thrombendvenectomy for Organized Portal Vein Thrombosis at the Time of Liver Transplantation , 2002, Annals of surgery.
[98] Steven R Deitcher,et al. Interpretation of the international normalised ratio in patients with liver disease , 2002, The Lancet.
[99] U. Nydegger,et al. Transient thrombopoietin peak after liver transplantation for end‐stage liver disease , 2001, British journal of haematology.
[100] R. Bentley,et al. Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold ischemic rat liver. , 2000, Gastroenterology.
[101] S. Schuetze,et al. Acquired protein S deficiency with multiple thrombotic complications after orthotopic liver transplant. , 1999, Transplantation.
[102] G. Leone,et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. , 1998, Blood.
[103] G. Alexander,et al. Thrombocytopenia following liver transplantation is associated with platelet consumption and thrombin generation , 1997, British journal of haematology.
[104] H. V. van Buuren,et al. Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays. , 1995, Thrombosis research.
[105] M. L. de la Mata,et al. Diminished anticoagulant and fibrinolytic activity following liver transplantation. , 1992, Transplantation.
[106] W. Millikan,et al. A hypercoagulable state follows orthotopic liver transplantation. , 1991, Hepatology.